Pleural effusion as a novel prognostic factor in metastatic thyroid carcinoma
Open Access
- 1 August 2020
- journal article
- conference paper
- Published by Bioscientifica in Endocrine Connections
- Vol. 9 (8) , 812-823
Abstract
Objective:: To identify novel prognostic risk factors and compare them with other known prognostic risk factors in follicular-cell-derived thyroid carcinoma (FDTC) with distant metastases. Methods:: A retrospective review was conducted of adult patients with metastatic FDTC seen at a tertiary care center between January 1990 and December 2010. A 15-year Kaplan–Meier survival estimate was created for overall survival (OS) and cancer-specific survival (CSS). Hazard ratios (HR) and P values from Cox proportional hazard models were used with a 95% CI. Results:: There were 143 patients (60.1% male, 39.9% female), of whom 104 (72.7%) patients had papillary, 30 (21.0%) had follicular, 5 (3.5%) had poorly differentiated, and 4 (2.8%) had Hürthle cell cancers. Median length of follow-up was 80.0 months (range 1.0–564.0). The 15-year mortality rate was 32.2% and cancer-specific mortality was 25.2%, with OS and CSS having the same risk factors. Lung was the most common site of metastases in 53 patients (37.1%), and patients with pleural effusions had significantly lower CSS (HR = 5.21, CI = 1.79–15.12). Additional risk factors for a decreased CSS included: older age upon diagnosis (>45 years, HR = 4.15, CI = 1.43–12.02), multiple metastatic locations (HR = 3.75, CI = 1.32–10.67), and incomplete/unknown tumor resection (HR = 2.35, CI = 1.18–4.67). Conclusion:: This study is the first to demonstrate that pleural effusion is a poor prognostic sign in patients with FDTC with distant metastases and compare this risk with other accepted prognostic variables.Keywords
This publication has 26 references indexed in Scilit:
- Notable Decrease of Malignant Pleural Effusion After Treatment with Sorafenib in Radioiodine-Refractory Follicular Thyroid CarcinomaThyroid®, 2014
- Malignant Pleural Effusion Resulting from Metastasis of Thyroid Primaries: A Cytomorphological AnalysisActa Cytologica, 2013
- Evaluating the Prognostic Factors Associated with Cancer-specific Survival of Differentiated Thyroid Carcinoma Presenting with Distant MetastasisAnnals of Surgical Oncology, 2012
- Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2012
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Management of Malignant Pleural EffusionsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Factors Related to the Survival of Papillary and Follicular Thyroid Carcinoma Patients with Distant MetastasesThyroid®, 1999
- Pleural Effusion in Patients With Differentiated Papillary Thyroid CancerSouthern Medical Journal, 1994
- The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients.The Journal of Clinical Endocrinology & Metabolism, 1992
- Pleural Effusion Resulting from Metastatic Papillary Carcinoma of the ThyroidChest, 1992